JP5801814B2 - 腸及び筋肉の回復 - Google Patents

腸及び筋肉の回復 Download PDF

Info

Publication number
JP5801814B2
JP5801814B2 JP2012532595A JP2012532595A JP5801814B2 JP 5801814 B2 JP5801814 B2 JP 5801814B2 JP 2012532595 A JP2012532595 A JP 2012532595A JP 2012532595 A JP2012532595 A JP 2012532595A JP 5801814 B2 JP5801814 B2 JP 5801814B2
Authority
JP
Japan
Prior art keywords
glp
composition
rats
composition according
recovery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012532595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507341A (ja
Inventor
ディディエ アタックス，
ディディエ アタックス，
オードリー コドラン‐レイゾン，
オードリー コドラン‐レイゾン，
イレネ コルテ‐テュラズ，
イレネ コルテ‐テュラズ，
デニス ブレイリー，
デニス ブレイリー，
ライディー コンバレット，
ライディー コンバレット，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Publication of JP2013507341A publication Critical patent/JP2013507341A/ja
Application granted granted Critical
Publication of JP5801814B2 publication Critical patent/JP5801814B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2012532595A 2009-10-07 2010-10-07 腸及び筋肉の回復 Active JP5801814B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09172398A EP2311486A1 (en) 2009-10-07 2009-10-07 GLP-2 for use in intestine and muscle recovery
EP09172398.1 2009-10-07
PCT/EP2010/065021 WO2011042501A2 (en) 2009-10-07 2010-10-07 The intestine and muscle recovery

Publications (2)

Publication Number Publication Date
JP2013507341A JP2013507341A (ja) 2013-03-04
JP5801814B2 true JP5801814B2 (ja) 2015-10-28

Family

ID=41611235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012532595A Active JP5801814B2 (ja) 2009-10-07 2010-10-07 腸及び筋肉の回復

Country Status (11)

Country Link
US (1) US20120270786A1 (enExample)
EP (2) EP2311486A1 (enExample)
JP (1) JP5801814B2 (enExample)
CN (1) CN102711803B (enExample)
AU (1) AU2010305420B2 (enExample)
BR (1) BR112012009380A2 (enExample)
CA (1) CA2776964C (enExample)
DK (1) DK2485756T3 (enExample)
ES (1) ES2539917T3 (enExample)
IN (1) IN2012DN03187A (enExample)
WO (1) WO2011042501A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2986156B2 (en) * 2013-04-15 2020-06-03 Société des Produits Nestlé S.A. Use of whey protein in combination with electrical muscle stimulation
JP6325215B2 (ja) * 2013-08-29 2018-05-16 テルモ株式会社 栄養補給用冷菓
BR112017005762B1 (pt) * 2014-10-14 2021-10-05 Société des Produits Nestlé S.A. Composição compreendendo uma fonte de proteína, e um antioxidante e seu uso
KR101661332B1 (ko) * 2015-05-28 2016-09-29 (의료)길의료재단 글루카곤 유사 펩타이드-1 수용체 항진제를 포함하는 근감소증 치료용 약학 조성물
US10993993B2 (en) 2015-05-28 2021-05-04 Immunoforge Co., Ltd. Pharmaceutical composition for treating muscle atrophy or sarcopenia including glucagon-like peptide (GLP-1) or GLP-1 receptor agonist
KR102119188B1 (ko) * 2018-11-13 2020-06-08 이뮤노포지 주식회사 글루카곤 유사 펩타이드-1(glp-1), glp-1 유래 펩타이드, 또는 glp-1 분해 억제제를 포함하는 근감소증 또는 근위축증 치료용 약학 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661123A (en) * 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients
US5990077A (en) * 1995-04-14 1999-11-23 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
US5834428A (en) * 1995-04-14 1998-11-10 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
US6852690B1 (en) * 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
EP2275438A1 (en) * 1996-04-12 2011-01-19 1149336 Ontario Inc. Glucagon-like peptide-2 analogs
CA2223198A1 (en) * 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
CA2236519C (en) * 1997-05-02 2011-09-13 1149336 Ontario Inc. Methods of enhancing functioning of the large intestine
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
PT1326630E (pt) * 2000-09-18 2008-09-02 Sanos Bioscience As Utilização de péptidos glp-2
US7186683B2 (en) * 2000-09-18 2007-03-06 Sanos Bioscience A/S Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
DK1360202T3 (da) * 2001-02-16 2008-09-22 Conjuchem Biotechnologies Inc Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser
KR20050059258A (ko) * 2002-10-14 2005-06-17 노보 노르디스크 에이/에스 Ｇｌｐ-2 화합물, 제제, 및 그것의 사용
US20040115708A1 (en) * 2002-10-28 2004-06-17 Ardies C. Murray Method of screening agents for the treatment and prevention of cancer and cachexia and the new use of specific agents for the treatment and prevention of cancer and cachexia
EP1633384B1 (en) * 2003-05-15 2012-03-14 Trustees Of Tufts College Stable analogs of glp-1
CN101175416A (zh) * 2005-04-06 2008-05-07 诺瓦提斯公司 从营养方面改善葡萄糖控制和胰岛素作用的方法和组合物
EP1971230A2 (en) * 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
AU2007319066B2 (en) * 2006-11-08 2013-09-19 Zealand Pharma A/S Selective glucagon-like-peptide-2 (GLP-2) analogues

Also Published As

Publication number Publication date
IN2012DN03187A (enExample) 2015-09-25
AU2010305420B2 (en) 2015-03-19
DK2485756T3 (en) 2015-06-08
EP2311486A1 (en) 2011-04-20
BR112012009380A2 (pt) 2021-06-22
EP2485756B1 (en) 2015-05-20
WO2011042501A3 (en) 2011-06-03
CA2776964C (en) 2019-03-05
HK1173949A1 (en) 2013-05-31
WO2011042501A2 (en) 2011-04-14
CN102711803A (zh) 2012-10-03
EP2485756A2 (en) 2012-08-15
US20120270786A1 (en) 2012-10-25
CA2776964A1 (en) 2011-04-14
AU2010305420A1 (en) 2012-05-10
ES2539917T3 (es) 2015-07-07
JP2013507341A (ja) 2013-03-04
CN102711803B (zh) 2017-02-22

Similar Documents

Publication Publication Date Title
CN101212911B (zh) 含水解的蛋白质的婴儿营养品
US6592863B2 (en) Nutritional composition
EP1675480B1 (en) Nutritional composition against side effects of chemotherapy of radiotherapy
US8372442B2 (en) Liquid nutritional composition for bariatric surgery patients
US8178487B2 (en) Method for providing glutamine
RU2445955C1 (ru) Дикарбоновые кислоты со средней длиной цепи, их производные и метаболические нарушения
JP2006503105A (ja) ロイシンに富んだ栄養的組成物
US20110039767A1 (en) Food compositions
RU2385647C2 (ru) Питание для пациентов, страдающих ожирением
JP2013507341A (ja) 腸及び筋肉の回復
WO2013148685A1 (en) Pea protein containing nutritional compositions
EP2954787A1 (en) Liquid enteral nutritional composition with a low monovalent metal ion content
BR112019009757A2 (pt) composição nutricional para uso em terapia de pacientes com sarcopenia e/ou fraqueza ou pacientes pré-sarcopênicos e/ou pré-fraqueza
US8722614B2 (en) Adiponectin production enhancer
EP1811865B1 (en) Infant nutrition with protease inhibitor
WO2005110124A1 (en) Composition and methods for nutritional management of patients with hepatic disease
US11058657B2 (en) Nutritional composition for use in therapy of cancer patients
HK1173949B (en) Glp-2 for use in the treatment of muscle atrophy

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150203

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150825

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150827

R150 Certificate of patent or registration of utility model

Ref document number: 5801814

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250